Dave’s Analysis 6/23/2025

Company Overview: Immunic Inc. (NASDAQ: IMUX) Immunic Inc. is a clinical-stage biopharmaceutical company pioneering the development of selective, orally administered immunology therapies. Headquartered in New York City (formerly San Diego), the company is focused on treating chronic inflammatory and autoimmune diseases such as ulcerative colitis, Crohn’s disease, relapsing-remitting and progressive multiple sclerosis, and psoriasis. Its […]